Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Maple Finance (SYRUP) Price & Performance

EnzymeTrade
Maple FinanceTrade

Price performance (Past 24H)

Key statistics

Enzyme vs Maple Finance — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Maple Finance trades at Rp3,447 (market cap Rp4,09T, Rp309,48M 24h volume). The key difference: Maple Finance is far larger — about 30492.8× Enzyme's market cap, and Enzyme's circulating supply is 3,3M MLN versus 1,2B SYRUP for Maple Finance. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Maple Finance for 13 Days on average.

MLNSYRUP
Market Cap
Rp134,13MRp4,09T
Volume (24h)
Rp104,56MRp309,48M
Circulating Supply
3,3M MLN1,2B SYRUP
Typical Hold Time
28 Days13 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.

Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.

Maple Finance

Maple Finance (SYRUP) trades at Rp3,445 with a market cap of Rp4.1T, showing a bullish technical signal supported by moving averages. Key indicators include RSI_12 at 78.73 (sell signal) and ADX above 45 indicating a strong trend. Support lies at Rp3,290 and resistance at Rp3,594. No major protocol updates or ecosystem news were found recently.

Overall outlook is cautiously optimistic due to strong trend signals, but overbought RSI suggests near-term pullback risk. Opportunities include potential breakout above resistance; major risks involve high volatility and lack of recent fundamental catalysts. Investors should monitor volume and key levels closely.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

SYRUP
43% Buy57% Sell
Avg holding period · 13 Days

Top news

Latest headlines on both assets

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Maple Finance

Maple, launched in 2021, is an on-chain asset manager that combines decades of experience in traditional finance and cryptocurrency. By merging capital markets expertise with DeFi innovation, Maple offers a variety of products, including secured lending, Bitcoin yield strategies, and structured financial instruments.

Read more on SYRUP